FROM CONCEPT TO MARKET
DEAD

Serial Number

78573983

Owner

Regulatory & Clinical Research Institute, Inc.

Attorney

Joshua G. Gigger

First Use Date

Sep 30, 2003

Filing Date

Feb 24, 2005

Add to watchlist:

No watchlists yet
View on USPTO

FROM CONCEPT TO MARKET Trademark

Serial Number: 78573983 • Registration: 3207404

FROM CONCEPT TO MARKET is a trademark filed by Regulatory & Clinical Research Institute, Inc. on February 24, 2005. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Regulatory & Clinical Research Institute, Inc. (3 trademarks)

5353 Wayzata Blvd., Suite 505
Minneapolis, MN 554161334

Entity Type: 03

Trademark Details

Filing Date

February 24, 2005

Registration Date

February 13, 2007

First Use Anywhere

September 30, 2003

First Use in Commerce

September 30, 2003

Published for Opposition

November 28, 2006

Cancellation Date

September 15, 2017

Goods & Services

Identification of regulatory strategies for product market applications and reimbursement; preparation and submission of product applications to the FDA and other regulatory agencies; preparing business reports for governmental agencies and medical journals resulting from clinical studies; providing reimbursement and health economic services, namely, researching and analyzing current reimbursement policies, product and procedure codes and pricing; providing due diligence services, namely, evaluating regulatory strategies, clinical strategies, product reimbursement strategies and quality systems on behalf of venture capitalists

Contract regulatory and clinical services, namely, strategy development in the nature of consulting services regarding scientific and technical aspects of clinical trials and submissions to the FDA and other regulatory agencies; designing, implementing and managing clinical trials for product testing and development purposes; developing and managing clinical studies, clinical protocol, data management and analysis for clinical trials; preparing scientific reports resulting from clinical studies; developing and managing regulatory quality systems and compliance matters for medical product manufacturers; designing and implementing pre-clinical research services, namely, scientific animal research; preparing scientific reports as to results of studies for governmental agencies and medical journals resulting from clinical studies; designing animal medical experiments; designing, implementing and analyzing human clinical studies, namely, protocol development, site initiation, database development and management and data analysis

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sep 15, 2017 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 13, 2016 REM2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 10, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 10, 2016 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 21, 2012 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 21, 2012 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 21, 2012 APRE
TEAS SECTION 8 & 15 RECEIVED
Feb 14, 2012 E815
REGISTERED-PRINCIPAL REGISTER
Feb 13, 2007 R.PR
PUBLISHED FOR OPPOSITION
Nov 28, 2006 PUBO
NOTICE OF PUBLICATION
Nov 8, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 6, 2006 PREV
ASSIGNED TO LIE
Sep 29, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2006 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2006 CRFA
PAPER RECEIVED
Aug 31, 2006 MAIL
FINAL REFUSAL E-MAILED
Feb 27, 2006 GNFR
FINAL REFUSAL WRITTEN
Feb 27, 2006 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2006 TROA
NON-FINAL ACTION E-MAILED
Sep 26, 2005 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2005 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2005 DOCK
NEW APPLICATION ENTERED
Mar 4, 2005 NWAP